Development of a lipid metabolism-related gene model to predict prognosis in patients with pancreatic cancer

Table 1 Clinical characteristics of the pancreatic cancer patients used in this study

Variables	TCGA data
Number of patients	176
Age (median, range)	65 (35-88)
Sex (%)
Female	80 (45.5%)
Male	96 (54.5%)
Grade (%)
Grade 1	30 (17%)
Grade 2	94 (53.4%)
Grade 3	48 (27.3%)
Grade 4	2 (1.1%)
Unknown	2 (1.1%)
Stage (%)
I	21 (11.9%)
II	145 (82.4%)
III	3 (1.7%)
IV	4 (2.3%)
Unknown	3 (1.7%)
Survival status
OS days (median)	464.5
Censored (%)	92 (52.3%)

TCGA: The Cancer Genome Atlas; OS: Overall survival.

Table 2 Baseline characteristics of pancreatic cancer patients in different risk groups

Characteristics	TCGA-PAAD cohort		P value
	High risk	Low risk
Sex (%)			0.354
Female	37	43
Male	51	45
Age (%)			0.450
≤ 65 yr	44	49
> 65 yr	44	39
Tumor grade (%)			0.271
G1+G2	59	65
G3+G4	27	23
Unknown	2	0
TNM stage (%)			0.779
I + II	84	82
III + IV	3	4
Unknown	1	2
Survival state			0.003
Alive	32	52
Deceased	56	36

TCGA: The Cancer Genome Atlas; PAAD: Pancreatic adenocarcinoma.